China Pharma Holdings, Inc. to Present at CLSA Emerging Markets Pharma Conference
HAIKOU, China, Dec. 1, 2010 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, is scheduled to present ...
China Pharma Holdings, Inc. to Present at Piper Jaffray Healthcare Conference
HAIKOU CITY, China, Nov. 29, 2010 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, is scheduled to pr...
China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results
HAIKOU CITY, China, Nov. 11, 2010 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE Amex: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceuticals company in China, today announced financial results for the third quarter ended September 30, 2010. Third Qu...
China Pharma Holdings, Inc. to Present at Upcoming Investment Conferences
HAIKOU CITY, China, Nov. 8, 2010 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, plans to present at...
China Pharma Holdings, Inc. to Report Third Quarter 2010 Financial Results on November 11, 2010
HAIKOU CITY, China, Nov. 3, 2010 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its third quarter 2010 financial results befo...
China Pharma Holdings, Inc. Successfully Completes Phase I Clinical Trials of New Anti-Drug-Resistance Antibiotic
-- Novel combination of 3rd generation cephalosporin and beta-lactamase inhibitor moves one step closer to China's large cephalosporin antibiotic market -- HAIKOU CITY, China, Sept. 22 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufacture...
China Pharma to Present at the Rodman & Renshaw Annual Global Investment Conference in New York on September 12 - 15, 2010
HAIKOU CITY, China, Sept. 10 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE Amex: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceutical company in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, has been invited t...
China Pharma Holdings, Inc. Reports Second Quarter 2010 Financial Results
HAIKOU CITY, China, Aug. 10 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceuticals company in China, today announced financial results for the second quarter ended June 30, 2010. Second Quarter...
China Pharma Holdings, Inc. to Report Second Quarter 2010 Financial Results on August 10, 2010
HAIKOU CITY, China, Aug. 3 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its second quarter 2010 financial results b...
CPHI to Present at the Global Hunter Securities China Conference in San Francisco on July 11 - 13, 2010
HAIKOU CITY, China, July 6 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceutical company in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, has been i...
China Pharma Holdings, Inc. CEO to Speak at Brean Murray, Carret & Co. 2010 Life Sciences Summit
HAIKOU CITY, China, May 13 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceuticals company in China, today announced that the Company's Chief Executive Officer and President, Ms. Zhilin Li, has bee...
China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results
HAIKOU CITY, China, May 11 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceuticals company in China, today announced financial results for the first quarter ended March 31, 2010. First Quart...
China Pharma Holdings, Inc. Announces May Investor Conference Participation
HAIKOU CITY, China, May 6 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceuticals company in China, today announced that it will participate in the following investor conferences: Piper Jaff...
China Pharma Holdings, Inc. to Report First Quarter 2010 Financial Results on May 11, 2010
HAIKOU CITY, China, May 4 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its first quarter 2010 financial results before ...
China Pharma Holdings, Inc. Retains CCG Investor Relations
HAIKOU CITY, China, April 29 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE Amex: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceuticals company in China, today announced that it has retained CCG Investor Relations to design and execute its investor...
China Pharma Holdings, Inc. Reports Full Year 2009 Financial Results
- 2009 Revenue Increased 21% to $61.7 Million - - Cashflow From Operations Increased 63% to $10.67 Million - - 2010 Guidance Issued - HAIKOU CITY, China, March 5 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE/Amex: CPHI), which develops, manufactures...
China Pharma Holdings, Inc. Announces March Conference Participation
HAIKOU CITY, China, March 1 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it will participate in the following conferences: -- Rodm...
China Pharma Holdings, Inc. to Report 2009 Financial Results on March 5, 2010
HAIKOU CITY, China, Feb. 27 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its full year 2009 financial results before the market o...
China Pharma Holdings, Inc. Completes Clinical Trials for Candesartan Anti-Hypertension Drug
-- Company Submits Production Application to SFDA -- HAIKOU CITY, China, Jan. 21 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company has ...
China Pharma Holdings, Inc. to Present at Brean Murray China Growth Conference
HAIKOU CITY, China, Nov. 18 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it will present at the Brean Murray, Carret & Co. 2009 China Growth Conferen...
